Partell Specialty Pharmacy Recalls Testosterone and Anastrozole Pellets for Sterility Concerns
Partell Specialty Pharmacy is recalling specific lots of Testosterone/Anastrozole pellets in Nevada due to a non-approved sterilization method.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for drug recalls involving potential health risks.
Plain-English summary
Partell Specialty Pharmacy is recalling specific lots of Testosterone/Anastrozole 200 mg/20 mg pellets packaged in amber vials. The recall is due to a lack of assurance of sterility, as the firm used a non-approved method of sterilization for these drug products.
The affected products are prescription-only and were distributed in Nevada. The recall includes specific lot numbers with expiration dates ranging from April 2018 to August 2018. Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the affected products.
The recalled product
- Product
- Testosterone/Anastrozole 200 mg/20 mg pellets packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.
- Manufacturer
- Partell Specialty Pharmacy
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot#: 20171116@3
- BUD 05/15/2018
- 20180221@72
- BUD
- 08/20/2018
- 20171130@79
- BUD 05/29/2018
- BUD 08/20/2018
- 20180206@115
- BUD 08/05/2018
- 20171023@98
- BUD 04/21/2018.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 49 recalled by Partell Specialty Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Partell Specialty Pharmacy
See all →- SeverePartell Specialty Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- HighPartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereFDA Recalls Testosterone/Anastrozole Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereTestosterone and Anastrazole Pellets Recalled for Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Testosterone and Anastrazole Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereQualgen Testosterone and Anastrozole Pellets Recalled for Sterility Concerns
FDA (Drugs) · 2018-11-14
- SevereWells Pharmacy Recalls Testosterone and Anastrazole Pellets Due to Potency Issues
FDA (Drugs) · 2016-11-16
- SevereTestosterone Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23